专题：Food Allergy and Anaphylaxis Research

This cluster of papers focuses on the diagnosis and management of food allergy, with an emphasis on anaphylaxis, allergen immunotherapy, peanut allergy, epidemiology, and prevalence in children. It covers topics such as IgE-mediated reactions, clinical features, oral immunotherapy, and the impact of food allergy on quality of life.
最新文献
Emergency management of ceftriaxone-induced Type II Kounis syndrome: A case report

article Full Text OpenAlex

Cold urticaria patients can be susceptible to anaphylaxis during diagnostic cold provocation tests

article Full Text OpenAlex

A rare case report of delayed thyroxine hypersensitivity: Challenges and management strategies

article Full Text OpenAlex

Safety evaluation of the food enzyme mannan endo‐1,4‐β‐mannosidase from the non‐genetically modified Aspergillus niger strain AE‐HCM

article Full Text OpenAlex

Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study

article Full Text OpenAlex

Purification of Prudu6 from Almond and Its Cross-Reactivity with Glym6 from Soybean

article Full Text OpenAlex

Food protein–induced enterocolitis syndrome oral food challenge with a single dose is safe enough and fast

letter Full Text OpenAlex

Catamenial anaphylaxis

letter Full Text OpenAlex

Oral Food Challenges for Food Protein‐Induced Enterocolitis Syndrome—A 10‐Year Multicentre Audit

article Full Text OpenAlex

Valacyclovir-induced neurotoxicity and nephrotoxicity in an elderly patient with a history of nephrectomy: a case report

article Full Text OpenAlex

近5年高被引文献
Atopic Dermatitis

review Full Text OpenAlex 501 FWCI19.798

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

article Full Text OpenAlex 444 FWCI65.432

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020

article Full Text OpenAlex 438 FWCI64.165

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020

article Full Text OpenAlex 411 FWCI36.684

EAACI guidelines: Anaphylaxis (2021 update)

article Full Text OpenAlex 410 FWCI54.426

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

article Full Text OpenAlex 377 FWCI76.915

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

article Full Text OpenAlex 368 FWCI52.553

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

article Full Text OpenAlex 350 FWCI76.876

EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)

article Full Text OpenAlex 338 FWCI47.642

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

article Full Text OpenAlex 321 FWCI46.896